Philipp Harter

Like other search engines (Google or Bing) Radaris collects information from public sources.

Social Networks featuring Philipp Harter

Linkedin

   
Philipp Harter
Philipp Harter

Locality: Swansea, United Kingdom
Summary: Prince of Wales Innovation Scholar bei Cell Therapy Ltd
Current: General Manager Europe at Cell Therapy Ltd Prince of Wales Innovation Scholar at Cell Therapy Ltd Financial Director at Peepo GPS Ltd see less...
Past: Studentischer Mitarbeiter at Helaba
Education:  University of Wales, Cardiff Management (2010-2012) Innovative commercialisation model for emerging medical technologies - Investigating and developing an innovative business model for novel therapeutics.
 Johann Wolfgang Goethe-Universitt Frankfurt am Main Wirtschaftswissenschaften (2002-2008) 

Industry: Biotechnology
Experience: Cell Therapy Ltd (Biotechnology industry): General Manager Europe,   
Cell Therapy Ltd (Biotechnology industry): Prince of Wales Innovation Scholar,  (March 2010-Present) 
Peepo GPS Ltd (Medical Devices industry): Financial Director,  (February 2010-Present) 
Helaba (Public Company; Banking industry): Studentischer Mit...
Interests: career opportunities, consulting offers, new ventures, job inquiries, expertise requests, business deals, reference requests, getting back in touch

References for Philipp Harter

Web Results

THERE was joy and despair as hundreds of football fans gathered in ...

German postgraduate student Philipp Harter, 29, described his team's performance in the 4-1 victory as fantastic. "It is one of the best we have played in the last year," said ...

Hospital Pharmacy Europe - Boehringer Ingelheim initiates ...

"Based on our good experience with this combination," said Dr. Philipp Harter MD , of AGO study group and principal investigator of the starting trial, "we look forward ...

Boehringer Ingelheim initiates first Phase III clinical trial in ...

"Based on our good experience with this combination," said Dr. Philipp Harter MD , of AGO study group and principal investigator of the starting trial, "we look forward to continue ...

CiteULike: Histological grading in a large series of advanced ...

... Stefan Kommoss, Dietmar Schmidt, Friedrich Kommoss, Juergen Hedderich, Philipp Harter, Jacobus Pfisterer, Andreas du Bois

CiteULike: Virchows Archiv (Online Firstâ„¢)

... Stefan Kommoss, Dietmar Schmidt, Friedrich Kommoss, et al. Juergen Hedderich, Philipp Harter, Jacobus Pfisterer, Andreas du Bois

Boehringer Ingelheim initiates first Phase III clinical trial in ...

"Based on our good experience with this combination," said Dr. Philipp Harter MD, of AGO study group and principal investigator of the starting trial, "we look forward to continue ...